Quantcast

Latest Argos Stories

2011-05-18 18:14:00

ROTTERDAM, The Netherlands, May 18, 2011 /PRNewswire/ -- - Largest Independent Energy Supplier of Western Europe in the Making Energy suppliers North Sea Group and Argos Oil are discussing a merger. If the talks are successful, this autumn will see the creation of the largest independent player on the North-west European market in, with more than 850 employees, a combined tank storage capacity of over 1.5 million m3 and annual turnover of approximately EUR 10 billion. The...

2011-05-04 07:00:00

DURHAM, N.C., May 4, 2011 /PRNewswire/ -- Argos Therapeutics today announced that its immunotherapy platform based on recombinant human soluble CD83 demonstrated significant promise for renal and heart transplantation. Two studies were presented at the 2011 American Transplant Congress meeting in Philadelphia. The first presentation, titled "Enrichment of Regulatory T Cells by Soluble CD83 Associated with Induction of Kidney Allograft Tolerance," detailed the indirect mechanism by...

2011-03-02 15:05:00

BOSTON, March 2, 2011 /PRNewswire/ -- Argos Therapeutics announced today that its Arcelis immunotherapy for the treatment of HIV, AGS-004, demonstrated positive outcomes with the primary endpoint of viral load control and a favorable safety and immunogenicity profile in a final analysis of a Phase 2a clinical trial. Data for AGS-004 were presented in a poster at the 18th Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. In the study, AGS-004 was safe and well...

2011-01-31 07:00:00

DURHAM, N.C., Jan. 31, 2011 /PRNewswire/ -- Argos Therapeutics announced today that interleukin (IL)-12 secretion can predict the potency of the company's Arcelis(TM) dendritic cell (DC) immunotherapy and can be used as a potency marker in a Phase 3 clinical trial testing the company's lead product, AGS-003, in metastatic renal cell carcinoma (mRCC). In vitro results published in the Journal of Immunotherapy demonstrate that the potency of mature CD40L RNA electroporated DCs correlates...

2010-11-30 07:00:00

DURHAM, N.C., Nov. 30, 2010 /PRNewswire/ -- Argos Therapeutics today announced that it has initiated dosing of patients in a Phase 2b clinical trial of its Arcelis(TM) personalized immunotherapy for the treatment of HIV patients, AGS-004. The Phase 2b trial is a multicenter, randomized, double-blind, placebo-controlled study in HIV infected patients receiving antiretroviral therapy (ART) to evaluate the efficacy and safety of AGS-004 when compared to placebo during an analytical...

2010-10-26 07:00:00

DURHAM, N.C., Oct. 26 /PRNewswire/ -- Argos Therapeutics today announced that it will host a Webinar with leading researchers in renal cell carcinoma (RCC) to discuss novel therapies, recently approved or in development, as well as the promise of personalized immunotherapy in the treatment of RCC. In light of the first FDA approval of an autologous cellular immunotherapy, Dendreon Corporation's PROVENGE(®), three researchers will provide different perspectives on...

2010-10-05 08:00:00

Luxury yacht series set for expansion PALM BEACH, FL, Oct. 5 /PRNewswire/ - Tricon Marine has signed a contract to build a new custom Argos Gulfstream 70 (G70) for a private European buyer. The G70 is the latest addition to Tricon's innovative, limited-edition Argos series. At a length of 70 feet (21.3 meters), the ruggedly stylish pilothouse yacht will be built at Tricon's state-of-the-art shipyard, with launch scheduled for late 2011. The new sale heralds the expansion of Tricon's Argos...

2010-09-08 08:00:00

Argos G92 is first China-built yacht to be named as finalist in prestigious Cannes competition PALM BEACH, FL, Sept. 8 /PRNewswire/ - Tricon Marine is pleased to announce that its Argos Gulfstream 92 (G92) has been chosen alongside the Ferretti Custom Line 124 and Sunseeker 130 Predator as a finalist in the "Flybridge over 24 meters - Innovation" category for the "World YACHTS Trophies". Tricon's Argos G92 has the distinction of being the first China-built yacht to reach the "World YACHTS...

2010-07-19 06:00:00

VIENNA, July 19 /PRNewswire/ -- Argos Therapeutics today announced that, in an interim analysis of a Phase 2 trial, its Arcelis immunotherapy targeted at HIV, AGS-004, demonstrated a significant reduction in viral load and a delay in viral rebound kinetics during a 12-week antiretroviral treatment interruption (ARTI) when compared to pre-ART viral loads. The data will be presented in an oral poster presentation session. ART represents a major breakthrough for the management of HIV-infected...

2010-02-09 08:00:00

-- HIGH-RESOLUTION PHOTOS AVAILABLE UPON REQUEST -- PALM BEACH, FL, Feb. 9 /PRNewswire/ - Tricon Marine's luxurious 92-foot (28-meter) Argos Gulfstream yacht ("Argos G92") will be on display at the upcoming Miami Yacht and Brokerage Show, which takes place February 11-15, 2010 in the heart of beautiful Miami Beach. You'll recognize the Argos G92 immediately by the yellow, black and white Glasair Sportsman float plane sitting on her spacious multipurpose deck. Offering more space and greater...


Latest Argos Reference Libraries

10_882dd38af9cdeb8842ce7e31c378113c2
2004-10-19 04:45:44

Perseus Constellation -- Location: Northern Hemisphere; Coordinates: Right Ascension: 03h; Declination: +45; Source: Greek Mythology Perseus was the son of the Greek god Zeus and the mortal princess Danae. Perseus' grandfather, Acrisius, the king of Argos, was warned by an oracle that he would be killed by his grandson. Acrisius locked his daughter Danae in a dungeon to prevent her bearing a child. Zeus found a way into her dungeon disguised as a shower of gold. When the child Perseus...

More Articles (1 articles) »
Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.